相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A multicenter, prospective study evaluating the impact of the clinical pharmacist-physician counselling on warfarin therapy management in Lebanon
Nermine S. Choumane et al.
BMC HEALTH SERVICES RESEARCH (2018)
Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study
Tze-Fan Chao et al.
CIRCULATION (2018)
Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the Atherosclerosis Risk in Communities Study
P. L. Lutsey et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the Real-World vs Clinical Trials
Jose Miguel Rivera-Caravaca et al.
MAYO CLINIC PROCEEDINGS (2018)
Genotype-guided warfarin therapy: current status
Leticia C. Tavares et al.
PHARMACOGENOMICS (2018)
Effect of increased time in the therapeutic range on atrial fibrillation outcomes within a centralized anticoagulation service
Elise Phelps et al.
THROMBOSIS RESEARCH (2018)
Improvement of time in therapeutic range with warfarin by pharmaceutical intervention
Alvaro Viquez-Jaikel et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2017)
Efficacy of protocol-based pharmacotherapy management on anticoagulation with warfarin for patients with cardiovascular surgery
Y. Katada et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2017)
Assessment of oral anticoagulation control at two pharmacist-managed clinics in Brazil
Rogerio Guimaraes de Lima Silva et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2017)
Effect of Standardized Warfarin Treatment Protocol on Anticoagulant Effect: Comparison of a Warfarin Medication Therapy Adherence Clinic with Usual Medical Care
Salihah Aidit et al.
FRONTIERS IN PHARMACOLOGY (2017)
Impact of a pharmacist-driven warfarin management protocol on achieving therapeutic International Normalized Ratios (Reprinted from Journal of Health-System Pharmacy Residents JHPR, vol 2, issue 1, 2013)
Amanda Downing et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2016)
Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial
Leiliane Rodrigues Marcatto et al.
BMC CARDIOVASCULAR DISORDERS (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2016)
Preventing Thrombosis to Improve Outcomes in Heart Failure Patients
Eduard Shantsila et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2016)
Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation
Leiliane Rodrigues Marcatto et al.
ONCOTARGET (2016)
Clinical impact of a pharmacist-led inpatient anticoagulation service: a review of the literature
Tiffany Lee et al.
INTEGRATED PHARMACY RESEARCH AND PRACTICE (2016)
Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry
Sean D. Pokorney et al.
AMERICAN HEART JOURNAL (2015)
Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study
Sumeet S. Chugh et al.
CIRCULATION (2014)
CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation
Paulo Caleb Junior Lima Santos et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Oral Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Walter Ageno et al.
CHEST (2012)
Approach to Outcome Measurement in the Prevention of Thrombosis in Surgical and Medical Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Gordon H. Guyatt et al.
CHEST (2012)
CYP2C9 and VKORC1 Polymorphisms Are Differently Distributed in the Brazilian Population According to Self-Declared Ethnicity or Genetic Ancestry
Renata Alonso Gadi Soares et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2012)
Potential benefits of warfarin monitoring by a clinical pharmacist in a long term care facility
Carol Motycka et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2012)
Impact of a Pharmacist-Led Warfarin Self-Management Program on Quality of Life and Anticoagulation Control: A Randomized Trial
Lucie Verret et al.
PHARMACOTHERAPY (2012)
Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand
Surasak Saokaew et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2012)
Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic
Stephanie Young et al.
BMC FAMILY PRACTICE (2011)
Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
A. John Camm et al.
EUROPEAN HEART JOURNAL (2010)
Effectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis
S. Saokaew et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Pharmacology and management of the vitamin K antagonists
Jack Ansell et al.
CHEST (2008)
Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
Stuart J. Connolly et al.
CIRCULATION (2008)
Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation A Systematic Review
Yi Wan et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2008)
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Robert G. Hart et al.
ANNALS OF INTERNAL MEDICINE (2007)
Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control - Results from SPORTIF III and IV
Harvey D. White et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism
NJGM Veeger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
分享论文
